+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Monoclonal Antibodies Market 2020-2024 - Product Image

Global Monoclonal Antibodies Market 2020-2024

  • ID: 5143070
  • Report
  • August 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • MORE
The global monoclonal antibodies market is poised to grow by $54.55 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period.

This report on the monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.

The market is driven by the introduction of low-priced biosimilar monoclonal antibodies, targeted therapeutic mechanism of action, and strong R&D pipeline. In addition, introduction of low-priced biosimilar monoclonal antibodies is anticipated to boost the growth of the market as well.

The monoclonal antibodies market analysis includes application segment and geographical landscapes.

The global monoclonal antibodies market is segmented as below:

By Application
  • Oncology
  • Autoimmune disorders
  • Infectious diseases
  • Other applications
By Geography
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the increasing cases of diseases like cancer and immunological disorders as one of the prime reasons driving the monoclonal antibodies market growth during the next few years. Also, rise in the number of companies venturing into the monoclonal antibodies space and growing pricing pressure in the monoclonal antibodies segment will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The report covers the following areas:
  • Monoclonal antibodies market sizing
  • Monoclonal antibodies market forecast
  • Monoclonal antibodies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading monoclonal antibodies market vendors that include AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi. Also, the monoclonal antibodies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019-2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Application
  • Market segments
  • Comparison by Application
  • Oncology - Market size and forecast 2019-2024
  • Autoimmune disorders - Market size and forecast 2019-2024
  • Infectious diseases - Market size and forecast 2019-2024
  • Other applications - Market size and forecast 2019-2024
  • Market opportunity by Application
Market Segmentation by Type
  • Segmentation by type of monoclonal antibodies
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Competitive Scenario
  • Vendor Landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2019-2024 ($ billion)
14: Global market: Year-over-year growth 2019-2024 (%)
15: Five forces analysis 2019 & 2024
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2019
22: Application - Market share 2019-2024 (%)
23: Comparison by Application
24: Oncology - Market size and forecast 2019-2024 ($ billion)
25: Oncology - Year-over-year growth 2019-2024 (%)
26: Autoimmune disorders - Market size and forecast 2019-2024 ($ billion)
27: Autoimmune disorders - Year-over-year growth 2019-2024 (%)
28: Infectious diseases - Market size and forecast 2019-2024 ($ billion)
29: Infectious diseases - Year-over-year growth 2019-2024 (%)
30: Other applications - Market size and forecast 2019-2024 ($ billion)
31: Other applications - Year-over-year growth 2019-2024 (%)
32: Market opportunity by Application
33: Type - Market share 2019-2024 (%)
34: Comparison by Type
35: Market opportunity by Type
36: Customer Landscape
37: Market share by geography 2019-2024 (%)
38: Geographic comparison
39: North America - Market size and forecast 2019-2024 ($ billion)
40: North America - Year-over-year growth 2019-2024 (%)
41: Europe - Market size and forecast 2019-2024 ($ billion)
42: Europe - Year-over-year growth 2019-2024 (%)
43: Asia - Market size and forecast 2019-2024 ($ billion)
44: Asia - Year-over-year growth 2019-2024 (%)
45: ROW - Market size and forecast 2019-2024 ($ billion)
46: ROW - Year-over-year growth 2019-2024 (%)
47: Key leading countries
48: Market opportunity by geography ($ billion)
49: Impact of drivers and challenges
50: Vendor landscape
51: Landscape disruption
52: Industry risks
53: Vendors covered
54: Market positioning of vendors
55: AbbVie Inc. - Overview
56: AbbVie Inc. - Business segments
57: AbbVie Inc. - Key offerings
58: AbbVie Inc. - Key customers
59: AbbVie Inc. - Segment focus
60: AstraZeneca Plc - Overview
61: AstraZeneca Plc - Product and service
62: AstraZeneca Plc - Key offerings
63: AstraZeneca Plc - Key customers
64: AstraZeneca Plc - Segment focus
65: Bristol-Myers Squibb Co. - Overview
66: Bristol-Myers Squibb Co. - Product and service
67: Bristol-Myers Squibb Co. - Key offerings
68: Bristol-Myers Squibb Co. - Key customers
69: Bristol-Myers Squibb Co. - Segment focus
70: F. Hoffmann-La Roche Ltd. - Overview
71: F. Hoffmann-La Roche Ltd. - Business segments
72: F. Hoffmann-La Roche Ltd. - Key offerings
73: F. Hoffmann-La Roche Ltd. - Key customers
74: F. Hoffmann-La Roche Ltd. - Segment focus
75: GlaxoSmithKline Plc - Overview
76: GlaxoSmithKline Plc - Business segments
77: GlaxoSmithKline Plc - Key offerings
78: GlaxoSmithKline Plc - Key customers
79: GlaxoSmithKline Plc - Segment focus
80: Johnson & Johnson - Overview
81: Johnson & Johnson - Business segments
82: Johnson & Johnson - Key offerings
83: Johnson & Johnson - Key customers
84: Johnson & Johnson - Segment focus
85: Merck & Co. Inc. - Overview
86: Merck & Co. Inc. - Business segments
87: Merck & Co. Inc. - Key offerings
88: Merck & Co. Inc. - Key customers
89: Merck & Co. Inc. - Segment focus
90: Novartis AG - Overview
91: Novartis AG - Business segments
92: Novartis AG - Key offerings
93: Novartis AG - Key customers
94: Novartis AG - Segment focus
95: Pfizer Inc. - Overview
96: Pfizer Inc. - Business segments
97: Pfizer Inc. - Key offerings
98: Pfizer Inc. - Key customers
99: Pfizer Inc. - Segment focus
100: Sanofi - Overview
101: Sanofi - Business segments
102: Sanofi - Key offerings
103: Sanofi - Key customers
104: Sanofi - Segment focus
105: Currency conversion rates for US$
106: Research Methodology
107: Validation techniques employed for market sizing
108: Information sources
109: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • MORE
The publisher recognizes the following companies as the key players in the global monoclonal antibodies market: AbbVie Inc., AstraZeneca Plc, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst said: According to the report, one of the major drivers for this market is the introduction of low-priced biosimilar monoclonal antibodies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll